BridgeMD
Tests treatment safety and results for Breast Edema
Official title Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
ClinicalTrials.gov ID: NCT07080476
What this study is testing
- What it's testing
- The goal of the KiTaLymph trial is to investigate whether the application of kinesio tape is effective in women with persistent (\>6 months) breast and/or truncal oedema after treatment for breast cancer. The main objectives are to assess whether kinesio taping: reduces pain and symptoms, decreases swelling, improves quality of life (QoL).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female patients previously treated for breast cancer.
- Suffering from persistent (\>6 months) breast and/or truncal oedema, established at least six months after completion of radiotherapy.
- Objective measurements:
- BrEQ score ≥9.
- PWC (LymphScanner) showing at least one of the following:
You likely can't join if
- Presence of skin infections or wounds of the breast/truncal region at the time of inclusion making it impossible to apply kinesio tape.
- Age under 18 years.
- Not able to read and understand Dutch language.
- Having received mastectomy.
- Metastatic breast cancer.
See the full eligibility criteria
- Female patients previously treated for breast cancer.
- Suffering from persistent (\>6 months) breast and/or truncal oedema, established at least six months after completion of radiotherapy.
- Objective measurements:
- BrEQ score ≥9.
- PWC (LymphScanner) showing at least one of the following:
- Truncal oedema: ratio ≥ 1.32.
- Breast oedema: ratio ≥ 1.28.
- Local PWC of 52.90%.
- Clinical evaluation:
- At least one positive sign of breast and/or truncal oedema such as:
- Visual swelling compared with the contralateral side.
- Visible imprint of the bra on the skin.
- Peau d'orange appearance on the breast.
- Presence of skin infections or wounds of the breast/truncal region at the time of inclusion making it impossible to apply kinesio tape.
- Age under 18 years.
- Not able to read and understand Dutch language.
- Having received mastectomy.
- Metastatic breast cancer.
The study team makes the final eligibility decision.
Where it's taking place
- Antwerp, Belgium
- Ghent, Belgium
- Kortrijk, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Antwerp, Belgium; Ghent, Belgium; Kortrijk, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.